BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 29033548)

  • 1. The new era of nanotechnology, an alternative to change cancer treatment.
    Jurj A; Braicu C; Pop LA; Tomuleasa C; Gherman CD; Berindan-Neagoe I
    Drug Des Devel Ther; 2017; 11():2871-2890. PubMed ID: 29033548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in nanotechnology for cancer therapy.
    Tang MF; Lei L; Guo SR; Huang WL
    Chin J Cancer; 2010 Sep; 29(9):775-80. PubMed ID: 20800018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale.
    Dreaden EC; El-Sayed MA
    Acc Chem Res; 2012 Nov; 45(11):1854-65. PubMed ID: 22546051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer nanotechnology: application of nanotechnology in cancer therapy.
    Misra R; Acharya S; Sahoo SK
    Drug Discov Today; 2010 Oct; 15(19-20):842-50. PubMed ID: 20727417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-drug delivery system: a promising approach against breast cancer.
    Malik JA; Ansari JA; Ahmed S; Khan A; Ahemad N; Anwar S
    Ther Deliv; 2023 May; 14(5):357-381. PubMed ID: 37431741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances of Nanotechnology in the Diagnosis and Therapy of Triple- Negative Breast Cancer (TNBC).
    Kanugo A; Gautam RK; Kamal MA
    Curr Pharm Biotechnol; 2022; 23(13):1581-1595. PubMed ID: 34967294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The brilliance of nanoscience over cancer therapy: Novel promising nanotechnology-based methods for eradicating glioblastoma.
    Shabani L; Abbasi M; Amini M; Amani AM; Vaez A
    J Neurol Sci; 2022 Sep; 440():120316. PubMed ID: 35777316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of Drug Delivery Technology and Nanomedicine by Using Gold Nanoparticles].
    Ozeki T; Tagami T
    Yakugaku Zasshi; 2021; 141(3):323-326. PubMed ID: 33642498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends.
    Ding H; Zhang J; Zhang F; Xu Y; Liang W; Yu Y
    Drug Deliv; 2022 Dec; 29(1):3218-3232. PubMed ID: 36259505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review.
    Calixto GM; Bernegossi J; de Freitas LM; Fontana CR; Chorilli M
    Molecules; 2016 Mar; 21(3):342. PubMed ID: 26978341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities in combinational chemo-immunotherapy for breast cancer using nanotechnology: an emerging landscape.
    Raikwar S; Jain A; Saraf S; Bidla PD; Panda PK; Tiwari A; Verma A; Jain SK
    Expert Opin Drug Deliv; 2022 Mar; 19(3):247-268. PubMed ID: 35184620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rise of gold nanoparticles as carriers of therapeutic agents.
    Pattnaik S; Thalluri C; Swain K
    Acta Chim Slov; 2023 Nov; 70(4):467-478. PubMed ID: 38124649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendrimers as nanoscale vectors: Unlocking the bars of cancer therapy.
    Dey AD; Bigham A; Esmaeili Y; Ashrafizadeh M; Moghaddam FD; Tan SC; Yousefiasl S; Sharma S; Maleki A; Rabiee N; Kumar AP; Thakur VK; Orive G; Sharifi E; Kumar A; Makvandi P
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):396-419. PubMed ID: 35700939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview.
    Kapalatiya H; Madav Y; Tambe VS; Wairkar S
    Drug Deliv Transl Res; 2022 Jun; 12(6):1293-1305. PubMed ID: 34251612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.
    Ho BN; Pfeffer CM; Singh ATK
    Anticancer Res; 2017 Nov; 37(11):5975-5981. PubMed ID: 29061776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotherapeutics for the Treatment of Cancer and Arthritis.
    Patel P; Meghani N; Kansara K; Kumar A
    Curr Drug Metab; 2019; 20(6):430-445. PubMed ID: 30479211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles in pancreatic cancer therapy: a detailed and elaborated review on patent literature.
    Singh M; Jana BK; Pal P; Singha I; Rajkumari A; Chowrasia P; Nath V; Mazumder B
    Expert Opin Ther Pat; 2023 Oct; 33(10):681-699. PubMed ID: 37991186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy.
    Bhatia R; Sharma A; Narang RK; Rawal RK
    Curr Mol Pharmacol; 2021; 14(3):350-366. PubMed ID: 32744982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique roles of nanotechnology in medicine and cancer-II.
    Alam F; Naim M; Aziz M; Yadav N
    Indian J Cancer; 2015; 52(1):1-9. PubMed ID: 26837958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocarriers for anticancer drugs--new trends in nanomedicine.
    Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
    Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.